Posted by Michael Wonder on 06 Jul 2022
TGA grants provisional determinations to Pfizer for COVID-19 vaccines to target Omicron variant
6 July 2022 - On 5 July 2022, the TGA granted two provisional determinations to Pfizer in relation to COVID-19 vaccines that target the Omicron variant.
The determinations refer to the following vaccines:
- A monovalent COVID-19 vaccine riltozinameran (Comirnary Omicron)
- A bivalent COVID-19 vaccine tozinameran & riltozinameran (Comirnary Bivalent)
